Breakthrough with cancer vaccine

Following successful pre-clinical trials, the Mater Research team, in collaboration with the University Of Queensland are ready to trial a new cancer vaccine in humans.

This is a major breakthrough in cancer vaccinations offering several key advantages over existing vaccines, with the potential to treat a variety of blood cancers and malignancies.

Read more

Join Our Mailing List